NASDAQ:NERV | Free Cash Flow | Minerva Neurosciences, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2013-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$5.43M
2025-12-31-$4.48M
2025-03-31-$4.07M
2024-12-31-$5.17M
2024-03-31-$6.09M
2023-12-31-$5.99M
2023-03-31-$115,407.00
2022-12-31-$4.11M
2022-03-31-$5.81M
2021-12-31-$4.83M
2021-03-31-$5.22M
2020-12-31-$7.16M
2020-03-31-$9.2M
2019-12-31-$14.18M
2019-03-31-$9.6M
2018-12-31-$9.8M
2018-03-31-$10.93M
2017-12-31-$8.91M
2017-03-31-$6.04M
2016-12-31-$8.93M
2016-03-31-$6.05M
2015-12-31-$6.6M
2015-03-31-$4.91M
2014-12-31-$5.02M$11,870.00-$5.03M
2014-03-31-$1.24M
2013-12-31-$1.21M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$13.51M
2024-12-31-$19.55M
2023-12-31-$14.78M
2022-12-31-$24.65M$16,326.00-$24.66M
2021-12-31-$24.6M
2020-12-31-$33.82M
2019-12-31-$43.43M
2018-12-31-$41.94M
2017-12-31$3.09M$52,400.00$3.04M
2016-12-31-$25.69M
2015-12-31-$24.27M
2014-12-31-$35.96M$45,609.00-$36.01M
2013-12-31-$2.16M$3,232.00-$2.16M